The Influence of Blood Groups on Diseases Pattern Globally: A Review of Literature

Main Article Content

James Inyang Asuquo
Dorathy Chioma Okpokam
Idongesit K. Isong

Abstract

The present survey reports the influence of blood groups on disease pattern in worldwide basis. Genetic factors have been associated with vulnerability or resistance to certain disease. For example, individuals who are heterozygous to haemoglobin S and haemoglobin E are resistant to infection with Plasmodium falciparum. The manifestation of metabolic syndrome, a sickness characterized by multiple risk factors like obesity, hypertension and glucose intolerance is also influenced by genetic and environmental factors. Several studies have established a relationship between ABO blood type and incidences of Plasmodium falciparum infection. This review brought to the fore the relationship between blood groups and susceptibility or resistance to disease. There is need for more studies to be carried out to unravel the exact mechanism how blood groups affect disease. It is recommended that individuals of various blood groups should know the different disease that they are prone to and avoid the predisposing factors to such diseases.   

Keywords:
Blood group, disease pattern, haemoglobin, microaerophilic bacteria.

Article Details

How to Cite
Asuquo, J., Okpokam, D., & Isong, I. (2019). The Influence of Blood Groups on Diseases Pattern Globally: A Review of Literature. Asian Journal of Medicine and Health, 16(3), 1-9. https://doi.org/10.9734/ajmah/2019/v16i330145
Section
Review Article

References

Chotivanich K, Udomusangpetch R, Pattanapanyasat K. HBE: A balance polymorphism protection against high Parasitaemia and severe P. falciparum malaria. Blood. 2002;100:1172-1176.

Haseeb MA, Thors C, Linder E, Eveland LK. Schistosomal mansoni: A chemoreceptor through N-acetyl-D-Galactosamine containing receptor in females, insight into increased severity in schistosomiasis in individuals with blood group A. Experimental Parasitology. 2008; 119:67-73.

Okoroiwu HU, Okafor IM. Demographic characteristics of blood and blood components transfusion recipients and pattern of blood utilization in a tertiary health institution in southern Nigeria. BMC Hematology. 2018;18:16.

Blackwell CC, Dundas S, James VS. Blood group and susceptibility to disease caused by Escherichia coli 0157. Journal of Infectious Disease. 2002;185: 393-396.

Sheinfield J, Schaeffer M, Cordon-Cardo C. Association of the Lewis blood group phenotype with recurrent U.T.I in woman. New England Journal of Medicine. 1989; 320:773-777.

Zakai NA, Judd SE, Alexander K, McClare LA, Kissela BM, Howard G, Cushman M. ABO blood group and stroke risk: the reason for geographical and racial differences in stroke study. Journal of Thrombosis and Haemostasis. 2014;12: 564-570.

Alexander KS, Zakai NA, Gibert S, McClure LA, Wadley V, Unverzagt F, Cushman M. ABO blood type, factor VIII and incidences of cognitive impairment in the REGARDS cohort. Neurology. 2014; 83:1271-1276.

Garatty G. Blood group and disease: A historical perspective. Tranfus. Med. Rev. 2000;14:291-301.

Mourant AE, Kopec AC, Damaniewska-Sobczak Y. Blood group and disease. Oxford University Press. 1978;105-107.

Glass RI, Holmgreen J, Haley CE. Predisposition to cholera of individuals with O blood group. Possible evolutionary significance. American Journal of Epidemiology. 1985;121:791-796.

Story JR, Castiho L, Chen Q, Daniels G, Denomme G, Flegel WA, Glasner G, de Hass M. (). International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meeting. ISBT Science Series. 2016;11:118-122.

Morgan WTJ, Watkin WM. Genetic and biochemical aspect of human blood group A, B and H, Le-a and Le-b specificity. British Medical Bulletin. 1969;25:30-34.

Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Mould JM. Blood group protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. National Academy of Sciences. 2007;104: 17471-17476.

Tewodros Z, Abraham D, Berhana E. Association of ABO blood group and Plasmodium falciparum malaria in Dore Bafeno area, southern Ethiopia. Asian Pacific Journal of Tropical Medicine. 2011; 11:60045-60047.

Parthirana SL, Alles HK, Banadara S, Phone-Kyaw M, Perera MK. ABO blood groups with severe Plasmodium falciparum malaria. Annals of Tropical Medicine and Parasitology. 2005;99:119-124.

Panda AK, Panda SK, Sahu AN, Triparthy R, Ravindran B, Das BK. Association of ABO blood group with severe falciparum in adult: A case control study and meta analysis. Malaria Journal. 2011;10: 309.

Degarege A, Medhin G, Animut A, Legess M, Erko B. Association of ABO blood group and P. falciparum malaria related out-comes: A cross-sectional study in Ethiopia. Acta Trop. 2012;123:164-169.

Loscertales MP, Owens SO, Donnell J, Bunn J, Bosch-capblanch X, Brabin BJ. ABO blood group phenotype and plasmodium falciparum malaria: Unlocking a pivotal mechanism. Advance parasito-logy. 2007;65:1-50.

Lublin DM, Grifith RC, Atkinson JP. Influence of glycosylation on allelic and cell specific Mr variation, receptor processing and ligand binding of the complement C3b/C4b receptor. J. Biol. Chem. 1986;261: 5736-5744.

Rout R, Dhangadamajhi G, Mohapatra BN, Kar SK, Ranji M. Genetic diversity ofPfEMP1- DBL1 and its association with severe malaria in hyper endemic state of India. Asian Pacific Journal of Tropical Medicine. 2010;3:505-509.

Jenkin PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor level: A biologic functions after all? Transfusion. 2006;46:1836-1844.

Daniels G. The molecular genetic of blood group polymorphism. Transplantation Immunology. 2005;14:143-153.

Jemal A, Bray F, Center MM. Global cancer statistic. Cancer Journal. 2011;61: 69-90.

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer Journal Clin. 2002;55:74-108.

Gouzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. International Journal of Cancer. 2002;100: 249-260.

Aird I, Bentall HH, Robert JAF. The relationship between cancer of the stomach and ABO blood groups. British Medical Journal. 1953;1:799-801.

Clarke CA. Blood group and disease. In: Steiberg AG. Editor Progress in Medical Genetic. 1961;1:81-119.

Garatty G. Do blood group have biological role? In: Garatty Immunobiology of transfusion medicine. Marcel Dekker Inc. New York. 1994;205-255.

Huang JY, Wang R, Gao YT, YUAN JM. ABO blood type and the risk of cancer. Findings from the Shangai cohort study. Plos One. 2017;12:e0184295.

Edgren G, Hjalgrim H, Rostgaard K. Risk of gastric cancer and peptic ulcer in relation to ABO blood type: A cohort study. American Journal of Epidemiology. 2010; 172:1280-1285.

Wang Z, Liu L, Ji J. ABO blood group system and gastric cancer: A case control study and meta-analysis. International Journal of Molecular Science. 2012;13: 13308-133021.

Rizato C, Kato I, Plummer M. Risk of advance cancer precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and Cag A status. International Journal of Cancer. 2013;133:315-322.

Colledge H, Cfasso J. Helicobacter pylori infection; 2017.
Available:www.health.com
[Accessed June 14, 2019]

Mattos LC, Rodrigues CJ, Sanches FE, Ruiz MA, Mureira HW. ABO, Lewis, secretor and non-secretor phenotypes in patients infected or uninfected by the Helicobacter pylori bacillus. Sao Paulo Medical Journal. 2002;120:55-58.

Jaff MS. Relationship between ABO blood group and Helicobacter pylori infection in symptomatic patients. Clinical Experi-mental Gastroenterology. 2011;4:221-226.

Alkout AM, Blackwell CC, Weir DM. Isolation of cell surface component of Helicobacter pylori that bind sH type 2, Lewis A, Lewis B antigen. Gastro Enterology. 1997;112:1179-1187.

Dickey W, Collins JSA, Watson RGP, Sloan JM. Secretor status and Helicobacter pylori infection are independent risk factor for gastroduodenal disease. Gut. 1993;3:351-353.

Aryana K, Keramati MR, Zakavi SR, Sadeghian MH, Akbari H. Association of H pylori infection with Lewis and ABO blood groups in dyspeptic patients. Nigerian Medical Journal. 2013;54:196-199.

Global Burden on Disease; 2015.

Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. Hpb. 2008;58:62.

Aird I, LEE DR, Roberts IA. ABO blood group and cancer of esophagus, cancer of pancreas and pituitary adenoma. British Medical Journal. 1960;1:1163-1166.

Macafee AL. ABO blood group and carcinoma of the pancreas. Ulster Medical Journal. 1964;33:129-131.

Vioque J, Walker AM. Pancreatic cancer and ABO type: A study of cases and controls. Medical and Clinical. 1991;96: 761-961.

Wolpin BM, Chan AT, Hart GE. ABO blood group and the risk of pancreatic cancer. Journal of National Cancer Institute. 2009; 101:1015-1023.

Ammundadotir L, Kraft P, Solomon RZ. Genome wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nature and Genetics. 2009;41:986-990.

Wolpin BM, Kraft P, Gross M. Pancreatic cancer risk and ABO blood group alleles. Result from Pancreatic Cancer Consortium. 2010;70:1015-1023.

Zhang BL, He N, Huang F, Chen KX. ABO blood group and risk of cancer: Systematic review and meta-analysis. Asian Journal of Cancer Prev. 2014;15:4643-4650.

Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori sero positivity, the risk of pancreatic cancer: a case control study. Journal of National Cancer Institute. 2010;102:502-505.

Centre for Disease Control; 2017.

Nordgren J, Kindberg E, Lindgren PE, Maussek A, Svensson L. Norovirus gastroenteritis outbreak with secretor independent susceptibility pattern. Emerging Infectious Disease. 2016;16:81-87.

Thorven M, Grahn A, Johansson H, Larson G, Svensson L. Homozygous nonsense mutation in human secretor (FUT2) Gene provides resistance to symptomatic to norovirus infection. Journal of Virology. 2005;79(24):15351-15355.

Larson MM, Rydell GE, Grahn A. Antibody prevalence and titre to norovirus correlate to secretor (FUT2), but not with ABO phenotype or Lewis (FUT3) genotype. Journal of Infectious Disease. 2006;194: 1422-1427.

Hutson AM, Atmar R, Graham DY. Norwalk virus infection disease associated with ABO blood group. Journal of Infectious Disease. 2002;194:1422-1427.

Tan M, Jiang X. The association of histo blood group antigen with susceptibility to norovirus infection may be strain specific rather than group dependent. Journal of Infectious Disease. 2008;198:940-941.

World Health Organization (WHO). Global Health Observatory (GHO) data: HIV/AIDS.
Available:www.who.gho/hiv/en
[Accessed June 14, 2019]

Okoroiwu HU, Okafor IM, Enosakhare AE, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria: An eleven years evaluation. BMC Public Health. 2018;18: 645.

Ali S, Niang MA, Ndoye I. Secretor polymorphism and human immunodefi-ciency virus infection in Senegalese woman. Journal of Infectious Disease. 2000;18:737-739.

Kinberg E, Hedeman B, Brat G. A nonsense mutation in the fucosyl transferase FUT2 gene affects the progression of HIV 1 infection. AIDS. 2000;20:685-689.

Chanzu NM, Mwanda W, Oyugi J, Anzak O. Mucosal blood group antigen expression profile and HIV infections. A study among female sex workers in Kenya. Plos One Journal. 2015;10:e0133049.

WHO. World Health Organization; 2008.

Capuzzo E, Bofanti C, Frantini F, Montors P, Turdo R. The relationship between ABO blood group and cardiovascular disease: Result from cardio risk programme. Annals of Transfusion Medicine. 2016;4:89.

Wautrech JC, Galle C, Motte S, Serene JP. The role of ABO blood group I the incidences of deep vein thrombosis. Thrombosis and Haemostasis. 1998;79: 688-695.

Koster T, Blann AD, Briet E. Role of clotting factor VIII and effect of von Willebrand factor on the occurrence of deep vein thrombosis. Lancet. 1995L345: 152-155.

Ohira T, Cushman M, Tsai MY. ABO blood group, other risk factors and incidences of venous thrombosis. The longitudinal investigation of thromboembolism etiology. Thrombosis and Haemostasis. 2007;5: 1455-1461.

Spiezia L, Campello E, Bon M. ABO blood group and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfusion. 2013;11:250-253.

Gill JC, Endros-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von willebrand disease. Blood. 1987;69:1691-1695.

Bowen DJ. Influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS 13 enzyme. Blood. 2005;106:1988-1991.

Horuk R, Chinis CE, Darbonne WC, Dolby TJ. A receptor for malaria parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science. 1993;261: 1162-1164.

Lewinson W. Medical microbiology and immunology. Examination board review. New York: Lange Medical Books/McGraw Hill. 2004;143:199-203.

Cavasini CE, Mattos LC, Couto AA. Plasmodium vivax infection among Duffy antigen negative individual from the Brazilian Amazon region: An exception? Society for Tropical Medicine. 2007;101: 1042-1044.